Mustapha Belaidi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mustapha Belaidi has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Saleh Bufarwa
Chemistry Department, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya
9 shared publications - Marei M. El-Ajaily
Department of Chemistry, Faculty of Science, University of Benghazi, Benghazi, Libya
4 shared publications - Leila Magdy Abbass
Department of Chemistry, Faculty of Science Zagazig University Zagazig Egypt
2 shared publications - Reem M. El-Sefait
Natural Resources and Environmental Sciences , Omar Al-Mukhtar University , El-Beida City , Libya
2 shared publications Abdulsalam Saleh
Department of Health Food Hygiene, Omar AL Mukhtar University, EL-Beida, Libya
1 shared publicationAmany A. Sayed
Zoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt
1 shared publication
Latest Publications
- 28 October 2026
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- p. 1-29
Integrated in vivo and in silico evaluation of methanolic Cinnamomum cassia extract: Antidiabetic, anti-inflammatory and thermodynamic insights
Type 2 diabetes (D2T) is characterized by persistent hyperglycemia and chronic low-grade inflammation. The methanolic extract of Cinnamomum cassia (C. cassia) was evaluated for its effects on glucose regulation and inflammatory status in Wistar rats with D2T induced by a 4-week high-fat diet followed by streptozotocin (35 mg/kg). HPLC analysis revealed trans-cinnamaldehyde (11.18 μg/g), cinnamic acid (9.2 μg/g), and other phenolic compounds including caffeic, ferulic, and sinapic acids. The extract was administered at 200 mg/kg daily for 28 days. Treatment significantly reduced fasting blood glucose (−60%), HbA1c (−66%), and insulin resistance (HOMA-IR −34%), while increasing circulating insulin levels ([Formula: see text]120%) and partially restoring [Formula: see text]-cell function (HOMA-[Formula: see text]825%). Glucose tolerance was markedly improved, as evidenced by a 55.9% decrease in glycemic AUC and a 157.1% increase in insulinemic AUC. Concomitantly, treatment significantly reduced pro-inflammatory markers, including IL-1[Formula: see text] (−32%), IL-6 (−32%), TNF-[Formula: see text] (−34%), and CRP (−35%), indicating marked attenuation of systemic inflammation. Mechanistic insights were obtained through molecular docking and 100-ns molecular dynamics simulations with MM/GBSA calculations against multiple targets including IL-1R (PDB 1B09), TNF-R (PDB 2AZ5), AMPK (PDB 4CFF), and PTP1B (PDB 2QBS). The major phenolic compounds formed thermodynamically stable complexes with favorable binding scores, with caffeic acid showing particularly strong free energy for IL-1R (−167.8 kcal/mol) and TNF-R (−178.8 kcal/mol). Sinapic acid exhibited the most favorable docking scores for AMPK (−5.69 kcal/mol) and PTP1B (−5.67 kcal/mol). RMSD values below 3 Å and stable radius of gyration profiles confirmed complex stability throughout the simulations. PCA and DCCM analyses revealed ligand-induced modulation of protein conformational dynamics. ADMET profiling indicated favorable physicochemical and drug-like properties for the major compounds. By integrating in vivo effects with quantitative thermodynamic analyses and expanded target profiling, this work demonstrates a multi-target mechanism through which C. cassia improves glycemic control and reduces systemic inflammation via stable interactions with inflammatory receptors, PTP1B, and AMPK, likely involving NF-[Formula: see text]B pathway inhibition. These findings provide a coherent mechanistic link between the chemical composition of the extract, its receptor interactions, and its physiological efficacy, highlighting its therapeutic potential in D2T.
- 28 October 2026
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- p. 1-29
Integrated in vivo and in silico evaluation of methanolic Cinnamomum cassia extract: Antidiabetic, anti-inflammatory and thermodynamic insights
Type 2 diabetes (D2T) is characterized by persistent hyperglycemia and chronic low-grade inflammation. The methanolic extract of Cinnamomum cassia (C. cassia) was evaluated for its effects on glucose regulation and inflammatory status in Wistar rats with D2T induced by a 4-week high-fat diet followed by streptozotocin (35 mg/kg). HPLC analysis revealed trans-cinnamaldehyde (11.18 μg/g), cinnamic acid (9.2 μg/g), and other phenolic compounds including caffeic, ferulic, and sinapic acids. The extract was administered at 200 mg/kg daily for 28 days. Treatment significantly reduced fasting blood glucose (−60%), HbA1c (−66%), and insulin resistance (HOMA-IR −34%), while increasing circulating insulin levels ([Formula: see text]120%) and partially restoring [Formula: see text]-cell function (HOMA-[Formula: see text]825%). Glucose tolerance was markedly improved, as evidenced by a 55.9% decrease in glycemic AUC and a 157.1% increase in insulinemic AUC. Concomitantly, treatment significantly reduced pro-inflammatory markers, including IL-1[Formula: see text] (−32%), IL-6 (−32%), TNF-[Formula: see text] (−34%), and CRP (−35%), indicating marked attenuation of systemic inflammation. Mechanistic insights were obtained through molecular docking and 100-ns molecular dynamics simulations with MM/GBSA calculations against multiple targets including IL-1R (PDB 1B09), TNF-R (PDB 2AZ5), AMPK (PDB 4CFF), and PTP1B (PDB 2QBS). The major phenolic compounds formed thermodynamically stable complexes with favorable binding scores, with caffeic acid showing particularly strong free energy for IL-1R (−167.8 kcal/mol) and TNF-R (−178.8 kcal/mol). Sinapic acid exhibited the most favorable docking scores for AMPK (−5.69 kcal/mol) and PTP1B (−5.67 kcal/mol). RMSD values below 3 Å and stable radius of gyration profiles confirmed complex stability throughout the simulations. PCA and DCCM analyses revealed ligand-induced modulation of protein conformational dynamics. ADMET profiling indicated favorable physicochemical and drug-like properties for the major compounds. By integrating in vivo effects with quantitative thermodynamic analyses and expanded target profiling, this work demonstrates a multi-target mechanism through which C. cassia improves glycemic control and reduces systemic inflammation via stable interactions with inflammatory receptors, PTP1B, and AMPK, likely involving NF-[Formula: see text]B pathway inhibition. These findings provide a coherent mechanistic link between the chemical composition of the extract, its receptor interactions, and its physiological efficacy, highlighting its therapeutic potential in D2T.
- 24 October 2026
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- p. 1-26
Integrated In Silico Profiling of Altissimacoumarin H in Prostate Cancer-Related Molecular Networks
Prostate cancer involves interconnected androgenic, inflammatory, hypoxia-related, receptor tyrosine kinase, and survival pathways, motivating hypothesis-generating multi-target analyses. This study investigated Altissimacoumarin H (ATSC), a naturally occurring terpenylated coumarin, using an integrated in silico workflow combining target prediction, network pharmacology, transcriptomic assessment, molecular docking, molecular dynamics (MD), ADME/toxicity prediction, and density functional theory (DFT). Target prediction yielded 192 putative ATSC-associated proteins. Intersection with 1074 prostate cancer-associated genes identified 55 common targets. STRING/Cytoscape analysis highlighted ten hub targets, including STAT3, EGFR, NFKB1, TNF, HIF1A, ESR1, HSP90AB1, MAPK1, PTGS2, and GSK3B, with enrichment in cancer-, inflammatory-, oxidative stress-, receptor-, and hormone-related pathways. Transcriptomic assessment provided limited contextual support: five common targets were significantly downregulated in GSE89223, while GEPIA showed significant expression-level support mainly for PTGS2. Docking suggested plausible ATSC binding modes across the selected proteins, and a 100-ns MD simulation of the MAPK1/ERK2–ATSC complex showed generally stable structural behavior, with recurrent contacts involving LYS54, LYS114, VAL39, ASP111, SER153, and LEU156. MM/GBSA analysis yielded a median binding-energy estimate of −62.02 kcal/mol. SwissADME and toxicity predictions indicated reasonable drug-like features but also P-gp, structural-alert, and toxicity liabilities. DFT analyses indicated moderate electronic reactivity. Overall, these findings generate testable computational hypotheses regarding ATSC within prostate cancer-related molecular networks that require experimental validation.
- 24 October 2026
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- p. 1-26
Integrated In Silico Profiling of Altissimacoumarin H in Prostate Cancer-Related Molecular Networks
Prostate cancer involves interconnected androgenic, inflammatory, hypoxia-related, receptor tyrosine kinase, and survival pathways, motivating hypothesis-generating multi-target analyses. This study investigated Altissimacoumarin H (ATSC), a naturally occurring terpenylated coumarin, using an integrated in silico workflow combining target prediction, network pharmacology, transcriptomic assessment, molecular docking, molecular dynamics (MD), ADME/toxicity prediction, and density functional theory (DFT). Target prediction yielded 192 putative ATSC-associated proteins. Intersection with 1074 prostate cancer-associated genes identified 55 common targets. STRING/Cytoscape analysis highlighted ten hub targets, including STAT3, EGFR, NFKB1, TNF, HIF1A, ESR1, HSP90AB1, MAPK1, PTGS2, and GSK3B, with enrichment in cancer-, inflammatory-, oxidative stress-, receptor-, and hormone-related pathways. Transcriptomic assessment provided limited contextual support: five common targets were significantly downregulated in GSE89223, while GEPIA showed significant expression-level support mainly for PTGS2. Docking suggested plausible ATSC binding modes across the selected proteins, and a 100-ns MD simulation of the MAPK1/ERK2–ATSC complex showed generally stable structural behavior, with recurrent contacts involving LYS54, LYS114, VAL39, ASP111, SER153, and LEU156. MM/GBSA analysis yielded a median binding-energy estimate of −62.02 kcal/mol. SwissADME and toxicity predictions indicated reasonable drug-like features but also P-gp, structural-alert, and toxicity liabilities. DFT analyses indicated moderate electronic reactivity. Overall, these findings generate testable computational hypotheses regarding ATSC within prostate cancer-related molecular networks that require experimental validation.
- 8 December 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2673-2694
Preparation, Identification, and Antimicrobial Analysis, Molecular Docking, Molecular Dynamics Simulation, ADMET, DFT, of Dual-Ligand Complexes of Schiff Bases with M (III) Ions (M = Fe, La, and Cr)
Novel mixed-ligand Schiff base complexes were synthesized by coordinating 2-[(1E)-N-(2-hydroxyphenyl)ethanimidoyl]phenol (L1) and o-phenylenediamine (L2) with Cr(III), Fe(III) and La(III) ions. Elemental analyses, molar conductance and spectroscopic data confirmed the formation of stable 1:1:1 [M:L1:L2] nonelectrolytic complexes. In vitro antimicrobial evaluation revealed that Cr(III) and Fe(III) complexes exhibited superior antibacterial activity, notably against E. coli (34 mm) and S. aureus (27–34 mm), surpassing the free ligand and Ampicillin. Cr(III) also showed the strongest antifungal activity against A. flavus and C. albicans, whereas La(III) exhibited limited effects. Molecular docking against bacterial and fungal targets (PDB IDs: 1NNI, 1T2P, 5OE3, 5V5Z, 6G9S, 7SV2) demonstrated enhanced binding affinities of the metal complexes, with Cr(III) showing the highest stability, further supported by MD simulations, MM/GBSA, PCA and DCCM analyses. In silico ADMET studies indicated high gastrointestinal absorption, blood–brain barrier permeability and overall compliance with drug-likeness rules. Cr(III) and Fe(III) complexes combined favorable solubility, bioavailability and metabolic stability, while La(III) showed reduced solubility and higher molecular weight. However, metal coordination significantly improves the biological activity of Schiff base ligands, highlighting Cr(III) and Fe(III) complexes as promising antimicrobial agents.
- 8 December 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2673-2694
Preparation, Identification, and Antimicrobial Analysis, Molecular Docking, Molecular Dynamics Simulation, ADMET, DFT, of Dual-Ligand Complexes of Schiff Bases with M (III) Ions (M = Fe, La, and Cr)
Novel mixed-ligand Schiff base complexes were synthesized by coordinating 2-[(1E)-N-(2-hydroxyphenyl)ethanimidoyl]phenol (L1) and o-phenylenediamine (L2) with Cr(III), Fe(III) and La(III) ions. Elemental analyses, molar conductance and spectroscopic data confirmed the formation of stable 1:1:1 [M:L1:L2] nonelectrolytic complexes. In vitro antimicrobial evaluation revealed that Cr(III) and Fe(III) complexes exhibited superior antibacterial activity, notably against E. coli (34 mm) and S. aureus (27–34 mm), surpassing the free ligand and Ampicillin. Cr(III) also showed the strongest antifungal activity against A. flavus and C. albicans, whereas La(III) exhibited limited effects. Molecular docking against bacterial and fungal targets (PDB IDs: 1NNI, 1T2P, 5OE3, 5V5Z, 6G9S, 7SV2) demonstrated enhanced binding affinities of the metal complexes, with Cr(III) showing the highest stability, further supported by MD simulations, MM/GBSA, PCA and DCCM analyses. In silico ADMET studies indicated high gastrointestinal absorption, blood–brain barrier permeability and overall compliance with drug-likeness rules. Cr(III) and Fe(III) complexes combined favorable solubility, bioavailability and metabolic stability, while La(III) showed reduced solubility and higher molecular weight. However, metal coordination significantly improves the biological activity of Schiff base ligands, highlighting Cr(III) and Fe(III) complexes as promising antimicrobial agents.
- Open Access
- 22 October 2025
- Published by Medical Research Center in AlQalam Journal of Medical and Applied Sciences
- p. 2378-2387
Schiff Base-Benzil of Iron (III), Cerium (IV) and Thorium (IV) Mixed Ligand Chelates: Preparation, Spectral Characterization, Antitumor Activity and Molecular Docking Studies
In the following study, Schiff base formed from the condensation of 2-hydroxyacetophenone and L-alanine as the main ligand (HL1) and benzil compound as secondary ligand were entered into the formation of three new combined ligand chelates of Fe(III), Ce(IV), and Th(IV) ions. The fashioned chelates were characterized through using numerous analytical and spectroscopic equipment. The analytical techniques showed a non-electrolytic nature character for all chelates; moreover, the CHNS elemental analyses exhibited the formation of the mixed ligand chelates in a 1:1:1 [ML1L2] ratio. Meanwhile, the infrared spectral information showed the bonding of the metal ions with the active organizations present within the free ligands (-C=N, NH2, -OH). Also, the electronic spectral results displayed the proper geometrical structures for the mixed ligand chelates. In vitro antitumor activity of a few synthesized compounds with human Hepatocellular Carcinoma cells (Hep-G2) was tested. Additionally, the molecular docking ligand interactions have been evaluated.
- 22 October 2025
- Published by Medical Research Center in AlQalam Journal of Medical and Applied Sciences
- p. 2378-2387
Open AccessSchiff Base-Benzil of Iron (III), Cerium (IV) and Thorium (IV) Mixed Ligand Chelates: Preparation, Spectral Characterization, Antitumor Activity and Molecular Docking Studies
In the following study, Schiff base formed from the condensation of 2-hydroxyacetophenone and L-alanine as the main ligand (HL1) and benzil compound as secondary ligand were entered into the formation of three new combined ligand chelates of Fe(III), Ce(IV), and Th(IV) ions. The fashioned chelates were characterized through using numerous analytical and spectroscopic equipment. The analytical techniques showed a non-electrolytic nature character for all chelates; moreover, the CHNS elemental analyses exhibited the formation of the mixed ligand chelates in a 1:1:1 [ML1L2] ratio. Meanwhile, the infrared spectral information showed the bonding of the metal ions with the active organizations present within the free ligands (-C=N, NH2, -OH). Also, the electronic spectral results displayed the proper geometrical structures for the mixed ligand chelates. In vitro antitumor activity of a few synthesized compounds with human Hepatocellular Carcinoma cells (Hep-G2) was tested. Additionally, the molecular docking ligand interactions have been evaluated.
- 22 October 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1935-1954
Pharmacophore-Based Discovery of Licoisoflavanone as a Dual CXCR4/CXCR7 Inhibitor for Coronary Artery Disease: Integration of Traditional Chinese Medicine and Modern Computational Approaches
Coronary artery disease (CAD) is still a primary cause of death worldwide, prompting the development of innovative therapeutic strategies. In this work, 149 possible candidates were identified by creating a ligand-based pharmacophore model of traditional Chinese herbal medicines using FDA-approved CAD drugs as templates. Licoisoflavanone (MOL004885) was identified as the most promising dual inhibitor by subsequent molecular docking against the chemokine receptors CXCR4 and CXCR7. It showed significant binding affinities of −10.1 kcal/mol and −9.5 kcal/mol, respectively. Licoisoflavanone’s stability inside the binding sites of both receptors was validated by molecular dynamics simulations conducted over 200 ns, and MMGBSA analysis revealed a particularly advantageous interaction with CXCR4. Stereoisomeric analysis of the [ ]- and [ ]-forms of Licoisoflavanone revealed comparable stability and interaction patterns with both receptors. Pharmacokinetic predictions demonstrated nonmutagenic properties and good oral absorption. Additionally, the chemical stability and reactivity balance of the molecule were confirmed using density functional theory (DFT) calculations. These findings further support the dual-targeting potential of both enantiomers. All of these results point to Licoisoflavanone as a good candidate for additional research and development as a novel therapeutic drug that targets CXCR4/CXCR7 in the treatment of CAD.
- 22 October 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1935-1954
Pharmacophore-Based Discovery of Licoisoflavanone as a Dual CXCR4/CXCR7 Inhibitor for Coronary Artery Disease: Integration of Traditional Chinese Medicine and Modern Computational Approaches
Coronary artery disease (CAD) is still a primary cause of death worldwide, prompting the development of innovative therapeutic strategies. In this work, 149 possible candidates were identified by creating a ligand-based pharmacophore model of traditional Chinese herbal medicines using FDA-approved CAD drugs as templates. Licoisoflavanone (MOL004885) was identified as the most promising dual inhibitor by subsequent molecular docking against the chemokine receptors CXCR4 and CXCR7. It showed significant binding affinities of −10.1 kcal/mol and −9.5 kcal/mol, respectively. Licoisoflavanone’s stability inside the binding sites of both receptors was validated by molecular dynamics simulations conducted over 200 ns, and MMGBSA analysis revealed a particularly advantageous interaction with CXCR4. Stereoisomeric analysis of the [ ]- and [ ]-forms of Licoisoflavanone revealed comparable stability and interaction patterns with both receptors. Pharmacokinetic predictions demonstrated nonmutagenic properties and good oral absorption. Additionally, the chemical stability and reactivity balance of the molecule were confirmed using density functional theory (DFT) calculations. These findings further support the dual-targeting potential of both enantiomers. All of these results point to Licoisoflavanone as a good candidate for additional research and development as a novel therapeutic drug that targets CXCR4/CXCR7 in the treatment of CAD.
- 9 October 2025
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 120 (Pt 2) , 108718
In silico identification of a prognostic gene signature and virtual screening for hepatocellular carcinoma
- 9 October 2025
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 120 (Pt 2) , 108718
In silico identification of a prognostic gene signature and virtual screening for hepatocellular carcinoma
- 19 December 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (1)
Anticancer Activity, DFT, Molecular Docking, ADMET, and Molecular Dynamics Simulations Investigations of Schiff Base Derived From 2,3‐Diaminophenazine and Its Metal Complexes
In our previous study, Schiff base (1) complexes derived from 2,3‐diaminophenazine and metal ions Co(II) (2), Ni(II) (3), Cu(II) (4), and Cd(II) (5) were synthesized and characterized, demonstrating a significant biological activity. This study investigates their anticancer potential, specifically against prostate cancer. The complexes exhibited notable reductions in cancer cell viability, with IC50 values of 0.531 μM Ni(II), 0.630 μM Cu(II), and 0.655 μM Co(II), comparable with the standard drug enzalutamide. The Co(II) complex showed the highest efficacy, while Cd(II) displayed the lowest (IC50 = 0.648 μM). The presence of a phenazine ring in these complexes enhances DNA binding, contributing to their anticancer effects. HOMO‐LUMO calculations revealed energy gaps ranging from 2.525 to 3.294 eV, indicating varying reactivity and potential for biological interactions. Molecular docking studies revealed that compound (1) exhibited the highest binding affinity (−9.19 kcal/mol) for the prostate cancer‐related receptor, with significant hydrogen bond interactions. Molecular dynamics simulations over 100 ns demonstrated stable binding, with RMSD values below 1.5 Å, and RMSF analysis provided insights into protein flexibility. ADMET studies revealed favorable drug‐like properties, including good gastrointestinal absorption (> 30%), high blood–brain barrier permeability (LogBBB = 0.64), and high human intestinal absorption (68.47%–88.79%). No inhibition of CYP2D6 was observed, suggesting low risk for drug–drug interactions. These Schiff base‐metal complexes show promising anticancer activity and favorable ADMET profiles, indicating their potential as therapeutic agents for prostate cancer treatment.
- 19 December 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (1)
Anticancer Activity, DFT, Molecular Docking, ADMET, and Molecular Dynamics Simulations Investigations of Schiff Base Derived From 2,3‐Diaminophenazine and Its Metal Complexes
In our previous study, Schiff base (1) complexes derived from 2,3‐diaminophenazine and metal ions Co(II) (2), Ni(II) (3), Cu(II) (4), and Cd(II) (5) were synthesized and characterized, demonstrating a significant biological activity. This study investigates their anticancer potential, specifically against prostate cancer. The complexes exhibited notable reductions in cancer cell viability, with IC50 values of 0.531 μM Ni(II), 0.630 μM Cu(II), and 0.655 μM Co(II), comparable with the standard drug enzalutamide. The Co(II) complex showed the highest efficacy, while Cd(II) displayed the lowest (IC50 = 0.648 μM). The presence of a phenazine ring in these complexes enhances DNA binding, contributing to their anticancer effects. HOMO‐LUMO calculations revealed energy gaps ranging from 2.525 to 3.294 eV, indicating varying reactivity and potential for biological interactions. Molecular docking studies revealed that compound (1) exhibited the highest binding affinity (−9.19 kcal/mol) for the prostate cancer‐related receptor, with significant hydrogen bond interactions. Molecular dynamics simulations over 100 ns demonstrated stable binding, with RMSD values below 1.5 Å, and RMSF analysis provided insights into protein flexibility. ADMET studies revealed favorable drug‐like properties, including good gastrointestinal absorption (> 30%), high blood–brain barrier permeability (LogBBB = 0.64), and high human intestinal absorption (68.47%–88.79%). No inhibition of CYP2D6 was observed, suggesting low risk for drug–drug interactions. These Schiff base‐metal complexes show promising anticancer activity and favorable ADMET profiles, indicating their potential as therapeutic agents for prostate cancer treatment.
- Open Access
- 29 July 2024
- Published by Walter de Gruyter GmbH in Reviews in Inorganic Chemistry
- Vol. 45 (1) , 105-124
Antituberculosis, antimicrobial, antioxidant, cytotoxicity and anti-inflammatory activity of Schiff base derived from 2,3-diaminophenazine moiety and its metal(II) complexes: structural elucidation, computational aspects, and biological evaluation
Enticed by the present scenario of infectious diseases, four new Co(II), Ni(II), Cu(II), and Cd(II) complexes of Schiff base ligand were synthesized from 6,6′-((1E-1′E)(phenazine-2,3-dielbis(azanylidene)-bis-(methanylidene)-bis-(3-(diethylamino)phenol)) (H 2 L) to ascertain as effective drug for antituberculosis, anti-inflammatory, antioxidant, cytotoxic and antimicrobial activities. The organic ligand and its metal(II) complexes were characterized by numerous physical and spectroscopic methods, which showed that the complexes have a general formula, [ML], (where M = Co(II) (C1), Ni(II) (C2), Cu(II) (C3) and Cd(II) (C4)), for metal complexes have been proposed and have a square planar geometry, are amorphous in nature, and are thermally stable. Data highlight obtained from activity testing against tuberculosis, inflammation, and oxidants that all compounds are significantly active against these symptoms. Also, was to evaluate the effectiveness of various compounds against bacterial and fungal strains. Specifically, four bacterial strains (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa) and two fungal strains (Aspergillus flavus and Candida albicans) were tested and compared to the results of some standard drugs. The results revealed that compound C4 was more effective against bacterial strains than the comparison standard drugs. In addition, C3 was found to be the most effective of the comparison antibiotics against fungi, while the other compounds showed moderate antifungal activity. Moreover, to support the vitro results, certain computational studies as molecular docking studies, DFT, MESP, and AMEDT were also conducted to confirm the effectiveness of an organic ligand and its complexes against tuberculosis. These studies revealed that C4 is the most effective against tuberculosis and has desirable effects such as absorption, no degradation and no hepatotoxicity, etc.
- 29 July 2024
- Published by Walter de Gruyter GmbH in Reviews in Inorganic Chemistry
- Vol. 45 (1) , 105-124
Open AccessAntituberculosis, antimicrobial, antioxidant, cytotoxicity and anti-inflammatory activity of Schiff base derived from 2,3-diaminophenazine moiety and its metal(II) complexes: structural elucidation, computational aspects, and biological evaluation
Enticed by the present scenario of infectious diseases, four new Co(II), Ni(II), Cu(II), and Cd(II) complexes of Schiff base ligand were synthesized from 6,6′-((1E-1′E)(phenazine-2,3-dielbis(azanylidene)-bis-(methanylidene)-bis-(3-(diethylamino)phenol)) (H 2 L) to ascertain as effective drug for antituberculosis, anti-inflammatory, antioxidant, cytotoxic and antimicrobial activities. The organic ligand and its metal(II) complexes were characterized by numerous physical and spectroscopic methods, which showed that the complexes have a general formula, [ML], (where M = Co(II) (C1), Ni(II) (C2), Cu(II) (C3) and Cd(II) (C4)), for metal complexes have been proposed and have a square planar geometry, are amorphous in nature, and are thermally stable. Data highlight obtained from activity testing against tuberculosis, inflammation, and oxidants that all compounds are significantly active against these symptoms. Also, was to evaluate the effectiveness of various compounds against bacterial and fungal strains. Specifically, four bacterial strains (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa) and two fungal strains (Aspergillus flavus and Candida albicans) were tested and compared to the results of some standard drugs. The results revealed that compound C4 was more effective against bacterial strains than the comparison standard drugs. In addition, C3 was found to be the most effective of the comparison antibiotics against fungi, while the other compounds showed moderate antifungal activity. Moreover, to support the vitro results, certain computational studies as molecular docking studies, DFT, MESP, and AMEDT were also conducted to confirm the effectiveness of an organic ligand and its complexes against tuberculosis. These studies revealed that C4 is the most effective against tuberculosis and has desirable effects such as absorption, no degradation and no hepatotoxicity, etc.
- Open Access
- 21 July 2024
- Published by Medical Research Center in AlQalam Journal of Medical and Applied Sciences
- p. 566-582
Synthesis, Characterization, Antimicrobial Activity, DFT, Molecular Docking, and ADMET of 4-Chlorophenyazolquniolin-8-ol and Its Metal Complexes
In this study, we prepared 4-chlorophenylazoquinoline, a derivative of 8-hydroxyquinoline, with Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) ions to create metal complexes. We used various physical and spectroscopic methods to characterize the compound and its metal complexes, including molar conductivity measurements, melting point analysis, elemental analysis, electronic absorption spectroscopy, mass spectrometry, magnetic resonance spectroscopy, infrared spectroscopy, and thermogravimetric analysis. The octahedral geometry of all prepared complexes has been confirmed. To assess the antimicrobial activity, we examined two types of bacterial strains and two types of fungal strains. The antimicrobial activity of the prepared compounds was observed, and the higher increase was observed in the copper complex. The compounds were studied computationally after optimizing the angles, lengths, and bonds using the basic set 6-31G(d,p)/LANL2DZ. The molecular docking study of the compounds with the Alzheimer's disease protein 4BDT showed significant activity in binding to the amino acids of HL, C1, C2, C3, C4, and C5 compounds, with affinity energies of -6.4, -6.9, -6.9, -6.7, and -7.2 kcal.mol-1 for the compounds, respectively. To evaluate the safety of the prepared compounds in different drug designs, we employed the ADMET study, reducing the risk of failure in advanced drug design stages. The results of the ADMET showed a relative decrease in the toxicity and carcinogenicity factor. However, there are indications of metabolic risk and cellular uptake, requiring further study.
- 21 July 2024
- Published by Medical Research Center in AlQalam Journal of Medical and Applied Sciences
- p. 566-582
Open AccessSynthesis, Characterization, Antimicrobial Activity, DFT, Molecular Docking, and ADMET of 4-Chlorophenyazolquniolin-8-ol and Its Metal Complexes
In this study, we prepared 4-chlorophenylazoquinoline, a derivative of 8-hydroxyquinoline, with Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) ions to create metal complexes. We used various physical and spectroscopic methods to characterize the compound and its metal complexes, including molar conductivity measurements, melting point analysis, elemental analysis, electronic absorption spectroscopy, mass spectrometry, magnetic resonance spectroscopy, infrared spectroscopy, and thermogravimetric analysis. The octahedral geometry of all prepared complexes has been confirmed. To assess the antimicrobial activity, we examined two types of bacterial strains and two types of fungal strains. The antimicrobial activity of the prepared compounds was observed, and the higher increase was observed in the copper complex. The compounds were studied computationally after optimizing the angles, lengths, and bonds using the basic set 6-31G(d,p)/LANL2DZ. The molecular docking study of the compounds with the Alzheimer's disease protein 4BDT showed significant activity in binding to the amino acids of HL, C1, C2, C3, C4, and C5 compounds, with affinity energies of -6.4, -6.9, -6.9, -6.7, and -7.2 kcal.mol-1 for the compounds, respectively. To evaluate the safety of the prepared compounds in different drug designs, we employed the ADMET study, reducing the risk of failure in advanced drug design stages. The results of the ADMET showed a relative decrease in the toxicity and carcinogenicity factor. However, there are indications of metabolic risk and cellular uptake, requiring further study.